Answers are grounded in this paper and cite their sources.
pharmacokinetic studies indicated that the agent was long-lived and orally bioavailable. Collectively our data further corroborate that aryl-fluorosulfates, when incorporated correctly in a ligand, can result in Lys-covalent agents with pharmacodynamic and pharmacokinetic properties that warrant their use in the design of pharmacological probes or even therapeutics.
No takes yet. Share an insight, caveat, or question.
Udompholkul et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: